Biopsy Needles Market by Type (Monopty Needle, Temno Needle), Procedure (Aspiration Biopsy, Core Biopsy, Vacuum-Assisted Biopsy), Category, Material, Purchasing Channel, Application, End User - Global Forecast 2025-2032
Description
The Biopsy Needles Market was valued at USD 735.49 million in 2024 and is projected to grow to USD 777.71 million in 2025, with a CAGR of 5.96%, reaching USD 1,169.50 million by 2032.
Introduction to the Critical Role and Evolving Significance of Biopsy Needles in Advancing Diagnostic Precision and Patient-Centered Interventional Care
Biopsy needles stand at the forefront of modern diagnostic and interventional medicine, enabling clinicians to obtain critical tissue samples with precision and minimal patient discomfort. These minimally invasive devices have become indispensable in oncology, nephrology, pulmonology, and a host of other specialties, as they facilitate early detection of disease and support personalized treatment pathways. Rapid advancements in needle design, coupled with the integration of high-resolution imaging guidance, have continually enhanced procedural accuracy, safety profiles, and patient satisfaction.
Moreover, demographic trends such as an aging global population and the rising prevalence of chronic conditions have intensified the demand for reliable diagnostic tools. In addition, healthcare systems worldwide are prioritizing value-based care initiatives that reward efficient, outcome-driven interventions. As a result, the biopsy needles landscape is evolving in response to both clinical imperatives and economic pressures. This introduction lays the groundwork for a comprehensive exploration of the forces reshaping the sector, highlighting the critical importance of strategic insight.
Understanding the Technological Innovations Patient-Centric Advances and Clinical Practices That Are Transforming the Biopsy Needles Landscape Across Healthcare Settings
The biopsy needles market is experiencing transformative shifts driven by technological breakthroughs and evolving clinical practices. High-definition imaging guidance systems, including ultrasound, CT, and MRI, are now routinely integrated with needle-based procedures, allowing real-time visualization that elevates sampling accuracy. Enhanced bevel geometries and sensor-enabled tips deliver superior sample integrity while reducing tissue trauma. Furthermore, patient-centric innovations such as ergonomic handles and single-use components underscore a growing emphasis on safety and comfort.
In addition, automation and digital connectivity are revolutionizing procedural workflows. Smart needle platforms that provide instantaneous feedback on tissue density and positioning are accelerating adoption in interventional radiology and pathology. Value-based care imperatives further incentivize the development of cost-effective solutions that streamline the diagnostic pathway. As these converging trends continue to gain traction, the biopsy needles landscape is being fundamentally redefined by seamless integration of advanced materials, precision engineering, and data-driven clinical support.
Assessing the Broad Economic and Operational Impacts of the 2025 United States Tariffs on Biopsy Needle Manufacturing Supply Chains and Market Dynamics
In 2025, the United States introduced a suite of tariffs targeting imported metals, high-performance polymers, and critical imaging components used in biopsy needle manufacturing. These measures have had a cascading effect on production economics, raising input costs and challenging traditional supply chain configurations. As companies grapple with elevated material expenses, there is increased impetus to reassess sourcing strategies, negotiate long-term supplier contracts, and identify cost mitigation opportunities.
Moreover, the tariff environment has prompted a strategic shift toward nearshoring and regional manufacturing partnerships. By localizing key production steps, manufacturers aim to buffer against currency fluctuations and logistic bottlenecks. In addition, investments in automation and lean manufacturing practices have been accelerated as a means to offset input cost pressures. Ultimately, successfully navigating these tariff-induced dynamics will require operational agility, proactive risk management, and a willingness to explore innovative production paradigms.
Exploring In-Depth Market Segmentation Insights That Reveal Critical Differences in Biopsy Needle Types Procedures Categories Materials Channels Applications and End Users
Segmentation analysis reveals nuanced distinctions in device design, clinical application, and customer engagement. Based on type, Monopty Needles continue to lead fine-needle aspiration procedures due to their slender profile and precision sampling capability, while Temno Needles offer enhanced core extraction for comprehensive histological evaluation in oncology and renal diagnostics. In terms of procedure, Aspiration Biopsy retains popularity for rapid cytological assessment, Core Biopsy is preferred for tissue architecture analysis, and Vacuum-Assisted Biopsy is gaining ground for larger sample volumes with fewer insertions.
Category segmentation highlights the trade-off between disposable products that minimize cross-contamination risk and reusable systems supported by rigorous sterilization protocols. Material innovations contrast traditional metal alloys with emerging plastic composites that deliver cost efficiencies and patient comfort. Purchasing channel trends show that offline distribution through established medical suppliers remains prevalent, especially in hospital networks, while online procurement is steadily gaining traction in ambulatory surgical centers and diagnostic clinics due to ease of ordering and expedited delivery. Application segmentation underscores demand peaks in breast biopsy screening programs, specialized liver and kidney interventions, lung nodule sampling, and prostate diagnostics. Finally, end user differentiation indicates that hospitals maintain the highest volume of procedures, diagnostic clinics focus on niche imaging specialties, and ambulatory surgical centers leverage rapid turnaround to expand patient throughput.
Providing Comprehensive Regional Perspectives on Biopsy Needle Adoption Growth Drivers and Strategic Opportunities Across the Americas Europe Middle East Africa and Asia-Pacific
Regional perspectives offer critical context for strategic planning. In the Americas, well-established healthcare infrastructure and supportive reimbursement frameworks drive high adoption rates, with the United States and Canada leading in advanced procedural volumes and domestic manufacturing capabilities. Transitioning to Europe, Middle East and Africa, Western European markets benefit from regulatory harmonization and robust clinical guidelines, while Middle Eastern nations are rapidly modernizing their healthcare systems. African markets, though still emerging, are supported by international partnerships and targeted screening initiatives that gradually enhance procedural access.
Shifting focus to Asia-Pacific, robust economic growth and expanding public health programs are fueling significant uptake. Government-led screening campaigns in China and India are broadening patient access, and developed markets such as Japan and South Korea continue to adopt premium device technologies. Across all regions, companies are customizing product portfolios, forging local partnerships, and adapting pricing strategies to align with diverse regulatory requirements and economic realities.
Analyzing Leading Companies Competitive Strategies Innovation Portfolios and Collaborative Initiatives That Are Shaping the Future of the Biopsy Needles Market
Leading industry players have undertaken ambitious R&D programs to advance bevel technology, integrate pressure-sensing capabilities, and ensure seamless compatibility with imaging systems. Collaborative initiatives with academic medical centers and specialized research organizations have accelerated clinical validation and regulatory approvals, enabling faster market entry. Additionally, mergers and acquisitions have become a key mechanism for portfolio expansion, as established firms acquire startups with niche expertise in vacuum-assisted systems or innovative polymer composites.
Strategic alliances in Asia-Pacific markets facilitate local production and streamline distribution networks, while partnerships with imaging technology providers enhance end-to-end procedural solutions. Firms are also investing in physician training and certification programs to bolster procedural proficiency and reinforce brand preference. Digital platforms for order management and supply chain optimization are gaining prominence, offering real-time inventory visibility and responsive customer support that strengthen long-term relationships.
Outlining Actionable Strategies for Industry Leaders to Capitalize on Emerging Trends Overcome Challenges and Drive Sustainable Growth in the Biopsy Needles Sector
Industry leaders must embrace a multifaceted strategic agenda to thrive in this dynamic environment. Prioritizing innovation in needle design-such as the integration of smart sensors and ergonomic enhancements-can differentiate offerings and improve patient outcomes. Simultaneously, diversifying supply chains through nearshoring and multi-sourcing strategies will reduce exposure to tariff and logistical risks, ensuring continuity of supply during market disruptions.
In addition, forging value-based partnerships with providers and payers will support outcome-driven pricing models that reflect procedural efficacy. Expanding geographic reach through targeted alliances and distribution agreements in emerging markets can unlock new growth avenues. Companies should also leverage digital procurement channels to streamline ordering and enhance customer engagement. Finally, embedding sustainable materials and eco-friendly packaging into product development initiatives aligns with environmental mandates and evolving stakeholder expectations, strengthening brand reputation and compliance credentials.
Detailing the Methodological Framework Research Design Data Collection and Analytical Approaches Underpinning the Biopsy Needles Market Insights and Findings
This analysis is built upon a comprehensive research methodology that integrates qualitative and quantitative approaches. Primary data collection involved in-depth interviews with key stakeholders, including device manufacturers, clinical specialists, supply chain experts, and regulatory authorities. Secondary research encompassed a review of scientific literature, patent filings, regulatory documentation, and publicly available clinical guidelines.
Quantitative data was gathered through structured surveys of suppliers, distributors, and end users, then triangulated with proprietary databases to ensure consistency and accuracy. The research design incorporated competitive benchmarking, supply chain mapping, and scenario analysis to identify market drivers, barriers, and strategic inflection points. Rigorous validation protocols, including cross-referencing and statistical consistency checks, underpin the credibility of the insights presented.
Summarizing Key Findings Synthesize Market Drivers Barriers and Future Trajectories to Illuminate Strategic Imperatives in the Evolving Biopsy Needles Landscape
The biopsy needles market is poised for continued evolution underpinned by technological innovation, shifting clinical protocols, and macroeconomic influences. The integration of advanced imaging guidance, sensor-enabled devices, and patient-centric design features will drive further adoption in both established and emerging markets. Concurrently, the introduction of tariffs and supply chain disruptions highlights the importance of operational resilience and strategic sourcing.
Segmentation insights underscore the need for tailored product strategies that address distinct procedural, material, and channel requirements. Regional heterogeneity demands nuanced market entry tactics, while competitive dynamics reflect an environment of consolidation and collaborative innovation. As stakeholders look ahead, those who balance innovation with agile execution and strategic foresight will emerge as leaders, shaping the trajectory of biopsy needle technology and its critical role in modern diagnostics.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Type
Monopty Needle
Temno Needle
Procedure
Aspiration Biopsy
Core Biopsy
Vacuum-Assisted Biopsy
Category
Disposable
Reusable
Material
Metal
Plastic
Purchasing Channel
Offline Sales
Online Sales
Application
Breast Biopsy
Kidney Biopsy
Liver Biopsy
Lung Biopsy
Prostate Biopsy
End User
Ambulatory Surgical Centers
Diagnostic Clinics
Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Argon Medical Devices, Inc.
B. Braun SE
Becton, Dickinson and Company
Biomedical Srl
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Doctor Japan Co., Ltd.
Freudenberg Medical, LLC
Geotek Medical
Hologic, Inc.
Inrad, Inc.
IZI Medical Products
Medax Srl
Medi-Tech Devices Pvt. Ltd.
Medtronic PLC
Merit Medical Systems, Inc.
Mermaid Medical Group
Olympus Corporation
Pajunk GmbH Medizintechnologie
Point Blank Medical
Remington Medical
Stryker Corporation
Volkmann MedizinTechnik GmbH
weLLgo Medical Products GmbH
Note: PDF & Excel + Online Access - 1 Year
Introduction to the Critical Role and Evolving Significance of Biopsy Needles in Advancing Diagnostic Precision and Patient-Centered Interventional Care
Biopsy needles stand at the forefront of modern diagnostic and interventional medicine, enabling clinicians to obtain critical tissue samples with precision and minimal patient discomfort. These minimally invasive devices have become indispensable in oncology, nephrology, pulmonology, and a host of other specialties, as they facilitate early detection of disease and support personalized treatment pathways. Rapid advancements in needle design, coupled with the integration of high-resolution imaging guidance, have continually enhanced procedural accuracy, safety profiles, and patient satisfaction.
Moreover, demographic trends such as an aging global population and the rising prevalence of chronic conditions have intensified the demand for reliable diagnostic tools. In addition, healthcare systems worldwide are prioritizing value-based care initiatives that reward efficient, outcome-driven interventions. As a result, the biopsy needles landscape is evolving in response to both clinical imperatives and economic pressures. This introduction lays the groundwork for a comprehensive exploration of the forces reshaping the sector, highlighting the critical importance of strategic insight.
Understanding the Technological Innovations Patient-Centric Advances and Clinical Practices That Are Transforming the Biopsy Needles Landscape Across Healthcare Settings
The biopsy needles market is experiencing transformative shifts driven by technological breakthroughs and evolving clinical practices. High-definition imaging guidance systems, including ultrasound, CT, and MRI, are now routinely integrated with needle-based procedures, allowing real-time visualization that elevates sampling accuracy. Enhanced bevel geometries and sensor-enabled tips deliver superior sample integrity while reducing tissue trauma. Furthermore, patient-centric innovations such as ergonomic handles and single-use components underscore a growing emphasis on safety and comfort.
In addition, automation and digital connectivity are revolutionizing procedural workflows. Smart needle platforms that provide instantaneous feedback on tissue density and positioning are accelerating adoption in interventional radiology and pathology. Value-based care imperatives further incentivize the development of cost-effective solutions that streamline the diagnostic pathway. As these converging trends continue to gain traction, the biopsy needles landscape is being fundamentally redefined by seamless integration of advanced materials, precision engineering, and data-driven clinical support.
Assessing the Broad Economic and Operational Impacts of the 2025 United States Tariffs on Biopsy Needle Manufacturing Supply Chains and Market Dynamics
In 2025, the United States introduced a suite of tariffs targeting imported metals, high-performance polymers, and critical imaging components used in biopsy needle manufacturing. These measures have had a cascading effect on production economics, raising input costs and challenging traditional supply chain configurations. As companies grapple with elevated material expenses, there is increased impetus to reassess sourcing strategies, negotiate long-term supplier contracts, and identify cost mitigation opportunities.
Moreover, the tariff environment has prompted a strategic shift toward nearshoring and regional manufacturing partnerships. By localizing key production steps, manufacturers aim to buffer against currency fluctuations and logistic bottlenecks. In addition, investments in automation and lean manufacturing practices have been accelerated as a means to offset input cost pressures. Ultimately, successfully navigating these tariff-induced dynamics will require operational agility, proactive risk management, and a willingness to explore innovative production paradigms.
Exploring In-Depth Market Segmentation Insights That Reveal Critical Differences in Biopsy Needle Types Procedures Categories Materials Channels Applications and End Users
Segmentation analysis reveals nuanced distinctions in device design, clinical application, and customer engagement. Based on type, Monopty Needles continue to lead fine-needle aspiration procedures due to their slender profile and precision sampling capability, while Temno Needles offer enhanced core extraction for comprehensive histological evaluation in oncology and renal diagnostics. In terms of procedure, Aspiration Biopsy retains popularity for rapid cytological assessment, Core Biopsy is preferred for tissue architecture analysis, and Vacuum-Assisted Biopsy is gaining ground for larger sample volumes with fewer insertions.
Category segmentation highlights the trade-off between disposable products that minimize cross-contamination risk and reusable systems supported by rigorous sterilization protocols. Material innovations contrast traditional metal alloys with emerging plastic composites that deliver cost efficiencies and patient comfort. Purchasing channel trends show that offline distribution through established medical suppliers remains prevalent, especially in hospital networks, while online procurement is steadily gaining traction in ambulatory surgical centers and diagnostic clinics due to ease of ordering and expedited delivery. Application segmentation underscores demand peaks in breast biopsy screening programs, specialized liver and kidney interventions, lung nodule sampling, and prostate diagnostics. Finally, end user differentiation indicates that hospitals maintain the highest volume of procedures, diagnostic clinics focus on niche imaging specialties, and ambulatory surgical centers leverage rapid turnaround to expand patient throughput.
Providing Comprehensive Regional Perspectives on Biopsy Needle Adoption Growth Drivers and Strategic Opportunities Across the Americas Europe Middle East Africa and Asia-Pacific
Regional perspectives offer critical context for strategic planning. In the Americas, well-established healthcare infrastructure and supportive reimbursement frameworks drive high adoption rates, with the United States and Canada leading in advanced procedural volumes and domestic manufacturing capabilities. Transitioning to Europe, Middle East and Africa, Western European markets benefit from regulatory harmonization and robust clinical guidelines, while Middle Eastern nations are rapidly modernizing their healthcare systems. African markets, though still emerging, are supported by international partnerships and targeted screening initiatives that gradually enhance procedural access.
Shifting focus to Asia-Pacific, robust economic growth and expanding public health programs are fueling significant uptake. Government-led screening campaigns in China and India are broadening patient access, and developed markets such as Japan and South Korea continue to adopt premium device technologies. Across all regions, companies are customizing product portfolios, forging local partnerships, and adapting pricing strategies to align with diverse regulatory requirements and economic realities.
Analyzing Leading Companies Competitive Strategies Innovation Portfolios and Collaborative Initiatives That Are Shaping the Future of the Biopsy Needles Market
Leading industry players have undertaken ambitious R&D programs to advance bevel technology, integrate pressure-sensing capabilities, and ensure seamless compatibility with imaging systems. Collaborative initiatives with academic medical centers and specialized research organizations have accelerated clinical validation and regulatory approvals, enabling faster market entry. Additionally, mergers and acquisitions have become a key mechanism for portfolio expansion, as established firms acquire startups with niche expertise in vacuum-assisted systems or innovative polymer composites.
Strategic alliances in Asia-Pacific markets facilitate local production and streamline distribution networks, while partnerships with imaging technology providers enhance end-to-end procedural solutions. Firms are also investing in physician training and certification programs to bolster procedural proficiency and reinforce brand preference. Digital platforms for order management and supply chain optimization are gaining prominence, offering real-time inventory visibility and responsive customer support that strengthen long-term relationships.
Outlining Actionable Strategies for Industry Leaders to Capitalize on Emerging Trends Overcome Challenges and Drive Sustainable Growth in the Biopsy Needles Sector
Industry leaders must embrace a multifaceted strategic agenda to thrive in this dynamic environment. Prioritizing innovation in needle design-such as the integration of smart sensors and ergonomic enhancements-can differentiate offerings and improve patient outcomes. Simultaneously, diversifying supply chains through nearshoring and multi-sourcing strategies will reduce exposure to tariff and logistical risks, ensuring continuity of supply during market disruptions.
In addition, forging value-based partnerships with providers and payers will support outcome-driven pricing models that reflect procedural efficacy. Expanding geographic reach through targeted alliances and distribution agreements in emerging markets can unlock new growth avenues. Companies should also leverage digital procurement channels to streamline ordering and enhance customer engagement. Finally, embedding sustainable materials and eco-friendly packaging into product development initiatives aligns with environmental mandates and evolving stakeholder expectations, strengthening brand reputation and compliance credentials.
Detailing the Methodological Framework Research Design Data Collection and Analytical Approaches Underpinning the Biopsy Needles Market Insights and Findings
This analysis is built upon a comprehensive research methodology that integrates qualitative and quantitative approaches. Primary data collection involved in-depth interviews with key stakeholders, including device manufacturers, clinical specialists, supply chain experts, and regulatory authorities. Secondary research encompassed a review of scientific literature, patent filings, regulatory documentation, and publicly available clinical guidelines.
Quantitative data was gathered through structured surveys of suppliers, distributors, and end users, then triangulated with proprietary databases to ensure consistency and accuracy. The research design incorporated competitive benchmarking, supply chain mapping, and scenario analysis to identify market drivers, barriers, and strategic inflection points. Rigorous validation protocols, including cross-referencing and statistical consistency checks, underpin the credibility of the insights presented.
Summarizing Key Findings Synthesize Market Drivers Barriers and Future Trajectories to Illuminate Strategic Imperatives in the Evolving Biopsy Needles Landscape
The biopsy needles market is poised for continued evolution underpinned by technological innovation, shifting clinical protocols, and macroeconomic influences. The integration of advanced imaging guidance, sensor-enabled devices, and patient-centric design features will drive further adoption in both established and emerging markets. Concurrently, the introduction of tariffs and supply chain disruptions highlights the importance of operational resilience and strategic sourcing.
Segmentation insights underscore the need for tailored product strategies that address distinct procedural, material, and channel requirements. Regional heterogeneity demands nuanced market entry tactics, while competitive dynamics reflect an environment of consolidation and collaborative innovation. As stakeholders look ahead, those who balance innovation with agile execution and strategic foresight will emerge as leaders, shaping the trajectory of biopsy needle technology and its critical role in modern diagnostics.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Type
Monopty Needle
Temno Needle
Procedure
Aspiration Biopsy
Core Biopsy
Vacuum-Assisted Biopsy
Category
Disposable
Reusable
Material
Metal
Plastic
Purchasing Channel
Offline Sales
Online Sales
Application
Breast Biopsy
Kidney Biopsy
Liver Biopsy
Lung Biopsy
Prostate Biopsy
End User
Ambulatory Surgical Centers
Diagnostic Clinics
Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Argon Medical Devices, Inc.
B. Braun SE
Becton, Dickinson and Company
Biomedical Srl
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Doctor Japan Co., Ltd.
Freudenberg Medical, LLC
Geotek Medical
Hologic, Inc.
Inrad, Inc.
IZI Medical Products
Medax Srl
Medi-Tech Devices Pvt. Ltd.
Medtronic PLC
Merit Medical Systems, Inc.
Mermaid Medical Group
Olympus Corporation
Pajunk GmbH Medizintechnologie
Point Blank Medical
Remington Medical
Stryker Corporation
Volkmann MedizinTechnik GmbH
weLLgo Medical Products GmbH
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Increasing adoption of core needle biopsy devices for personalized oncology treatment planning
- 5.2. Integration of artificial intelligence guidance systems in biopsy needle placement for enhanced accuracy
- 5.3. Rising demand for single-use disposable biopsy needles driven by infection control and regulatory compliance incentives
- 5.4. Development of cryobiopsy needle techniques for improved lung tissue sampling in interventional pulmonology practice
- 5.5. Emergence of steerable and flexible biopsy needles optimized for challenging anatomical site access in minimally invasive procedures
- 5.6. Expansion of liquid biopsy alternatives reducing reliance on traditional needle sampling in oncology diagnostics pipelines
- 5.7. Collaborative partnerships between medical device manufacturers and imaging software providers for real-time needle navigation solutions
- 5.8. Advancements in biocompatible nitinol and polymer blend materials enhancing biopsy needle durability and patient safety profiles
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Biopsy Needles Market, by Type
- 8.1. Monopty Needle
- 8.2. Temno Needle
- 9. Biopsy Needles Market, by Procedure
- 9.1. Aspiration Biopsy
- 9.2. Core Biopsy
- 9.3. Vacuum-Assisted Biopsy
- 10. Biopsy Needles Market, by Category
- 10.1. Disposable
- 10.2. Reusable
- 11. Biopsy Needles Market, by Material
- 11.1. Metal
- 11.2. Plastic
- 12. Biopsy Needles Market, by Purchasing Channel
- 12.1. Offline Sales
- 12.2. Online Sales
- 13. Biopsy Needles Market, by Application
- 13.1. Breast Biopsy
- 13.2. Kidney Biopsy
- 13.3. Liver Biopsy
- 13.4. Lung Biopsy
- 13.5. Prostate Biopsy
- 14. Biopsy Needles Market, by End User
- 14.1. Ambulatory Surgical Centers
- 14.2. Diagnostic Clinics
- 14.3. Hospitals
- 15. Biopsy Needles Market, by Region
- 15.1. Americas
- 15.1.1. North America
- 15.1.2. Latin America
- 15.2. Europe, Middle East & Africa
- 15.2.1. Europe
- 15.2.2. Middle East
- 15.2.3. Africa
- 15.3. Asia-Pacific
- 16. Biopsy Needles Market, by Group
- 16.1. ASEAN
- 16.2. GCC
- 16.3. European Union
- 16.4. BRICS
- 16.5. G7
- 16.6. NATO
- 17. Biopsy Needles Market, by Country
- 17.1. United States
- 17.2. Canada
- 17.3. Mexico
- 17.4. Brazil
- 17.5. United Kingdom
- 17.6. Germany
- 17.7. France
- 17.8. Russia
- 17.9. Italy
- 17.10. Spain
- 17.11. China
- 17.12. India
- 17.13. Japan
- 17.14. Australia
- 17.15. South Korea
- 18. Competitive Landscape
- 18.1. Market Share Analysis, 2024
- 18.2. FPNV Positioning Matrix, 2024
- 18.3. Competitive Analysis
- 18.3.1. Argon Medical Devices, Inc.
- 18.3.2. B. Braun SE
- 18.3.3. Becton, Dickinson and Company
- 18.3.4. Biomedical Srl
- 18.3.5. Boston Scientific Corporation
- 18.3.6. Cardinal Health, Inc.
- 18.3.7. Cook Group Incorporated
- 18.3.8. Doctor Japan Co., Ltd.
- 18.3.9. Freudenberg Medical, LLC
- 18.3.10. Geotek Medical
- 18.3.11. Hologic, Inc.
- 18.3.12. Inrad, Inc.
- 18.3.13. IZI Medical Products
- 18.3.14. Medax Srl
- 18.3.15. Medi-Tech Devices Pvt. Ltd.
- 18.3.16. Medtronic PLC
- 18.3.17. Merit Medical Systems, Inc.
- 18.3.18. Mermaid Medical Group
- 18.3.19. Olympus Corporation
- 18.3.20. Pajunk GmbH Medizintechnologie
- 18.3.21. Point Blank Medical
- 18.3.22. Remington Medical
- 18.3.23. Stryker Corporation
- 18.3.24. Volkmann MedizinTechnik GmbH
- 18.3.25. weLLgo Medical Products GmbH
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
